Cochrane Abstracts
Brivaracetam add‐on therapy for drug‐resistant epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Brivaracetam Add‐on Therapy for Drug‐resistant Epilepsy." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438529/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy. Accessed 26 September 2023.
Brivaracetam add‐on therapy for drug‐resistant epilepsy. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438529/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy. Accessed September 26, 2023.
Brivaracetam add‐on therapy for drug‐resistant epilepsy. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438529/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy
Brivaracetam Add‐on Therapy for Drug‐resistant Epilepsy [Internet]. In: Cochrane Abstracts. [cited 2023 September 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438529/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Brivaracetam add‐on therapy for drug‐resistant epilepsy
ID - 438529
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438529/all/Brivaracetam_add‐on_therapy_for_drug‐resistant_epilepsy
DB - Evidence Central
DP - Unbound Medicine
ER -
